Technology

The Impact of Impaired Healing

0 M
People in the US affected by impaired healing.1
$ 0 B+
Economic impact of chronic wounds to Medicare.2
0 %

US population experiencing quality of life impact due to impaired healing.3

Complexity of the problem.

Healing is a multistep process where challenges can arise at any stage. 
Conventional therapies often fall short due to multifaceted nature of these challenges

Addressing healing complexity with a sophisticated system.

Living cells produce signals to direct healing.

biomesh tissue with new cells

Bioabsorbable material provides framework for new tissue formation.

Novel tissue healing technology unlocks cellular healing capabilities in a localized treatment system.

Innovation built on proven technology.

Tissue healing system derived from the combination of mesenchymal stem cells and bioabsorbable materials.

Bioabsorbable materials have a long history of use in implantable medical devices.

white biomesh tissue

Mesenchymal stem cells have a track record of safety across multiple clinical uses.

about 30 blue cells with shadows

Many versatile forms.

Enabling treatment across debilitating conditions.

Cutting edge implantable cell therapy can be customized for multiple indications, enabling treatment across a range of high potential therapeutic areas.

Avobis offers hope for patients with debilitating conditions due to impaired healing by developing implantable cell therapies for incurable conditions.

Tiffany J. Brown, PhD

Chief Executive Officer

Tiffany leads Avobis Bio as Chief Executive Officer, Chief Compliance Officer and Board Member. She has been passionate about regenerative medicine for 25 years and focused her career on ensuring patients have access to therapies to transform their lives. In her early career, Tiffany developed new products from clinical concept through technology development, global regulatory approvals and commercial sales. She went on to lead a multi-million dollar global portfolio of therapeutics for general surgical, bariatric and colorectal conditions with assets from pre-clinical stage to market leaders. Tiffany was instrumental in the formation of Avobis Bio, bringing together capabilities of Gore and Mayo Clinic, establishing the team and accelerating operational execution. She holds a PhD in Biomedical Engineering from Georgia Tech and Emory University. Tiffany enjoys immersion in global cultures, opportunities to travel and staying active with her husband and children.